Adina Turcu
@adinaturcu.bsky.social
44 followers 39 following 2 posts
Posts Media Videos Starter Packs
Reposted by Adina Turcu
nejm.org
New in the October 9, 2025, issue of NEJM:

Baxdrostat Efficacy and Safety in Uncontrolled Hypertension (BaxHTN phase 3 trial) nej.md/4my7xUZ

Nexiguran Ziclumeran in ATTR with Polyneuropathy nej.md/46Qhur7

#MedSky
Images and descriptions of what's new on NEJM.org this week  
Reposted by Adina Turcu
endocrinesociety.bsky.social
Endocrine Feedback Loop | Listen to Oksana Hamidi, DO, MSCS, and Jill Wagoner, MD, discuss a recent #JCEM article (http://bit.ly/4pC3BEl)on mild autonomous cortisol secretion (MACS) is associated with increased risk of vertebral fractures (VFx) (https://bit.ly/EFL065)
Reposted by Adina Turcu
drwanpen.bsky.social
Got to Baltimore #Hypertension25 so excited to see friends and colleagues talking about high BP ! @ahascience.bsky.social @giaconajohn.bsky.social
Reposted by Adina Turcu
eurojendo.bsky.social
A global real-world study assessing total time to adrenalectomy in primary aldosteronism by Charmaine Ter et al

EJE Volume 193, Issue 1, July 2025
Open access article 👉 doi.org/10.1093/ejen...

#endocrinology #adrenalectomy #aldosteronism
adinaturcu.bsky.social
#ENDO2026 Welcomes Your Ideas | Our annual meeting will take place in Chicago, IL, June 13–16, and I’m inviting YOU to shape the program💡Submit your symposium proposal or session suggestion by Tuesday, September 2: bit.ly/4flCMjl
#endocrinology @TheEndoSociety
ENDO 2026 Session Submissions
ENDO wouldn’t be possible without the insight and expertise of the Endocrine community. Your ideas are essential to building a dynamic, forward-thinking program that reflects the full breadth of our f...
bit.ly
Reposted by Adina Turcu
drwanpen.bsky.social
Join us @jordybc.bsky.social , Keith Ferdinand, and Dan Jones unpacking 2025 AHA/ACC guidelines on Thursday Aug 28 bit.ly/Guideline25W... @UTSWInternalMed @utswheart
Reposted by Adina Turcu
endocrinesociety.bsky.social
“Diabetes and Pregnancy” has been long anticipated. For the first time, clinicians will have a definitive guide on treating these patients that now includes the most recent technological breakthroughs in diabetes treatments. Read more in @endocrinenews.bsky.social: bit.ly/45FR4rx #endocrinology
Redefining Diabetes Care in Pregnancy - Endocrine News
New Endocrine Society and European Endocrine Society guidelines provide a much-needed update Making its debut at ENDO 2025, “Diabetes and Pregnancy: An Endocrine Society and European Society of Endocr...
bit.ly
Reposted by Adina Turcu
nejm.org
NEJM.org @nejm.org · Aug 6
Shalender Bhasin, MB, BS, and Peter J. Snyder, MD, review available data on the benefits and risks of testosterone treatment in middle-aged and older men with moderate hypogonadism. Learn more in a new Review Article: nej.md/4ooeFo7

#MedSky #EndoSky #Urology
Review Article 
Testosterone Treatment in Middle-Aged and Older Men with Hypogonadism 

An illustrated diagram showing the pathways mediating the physiological and clinical effects of testosterone in men.
Reposted by Adina Turcu
anandvaidya17.bsky.social
New Primary Aldosteronism Guidelines - simpler, streamlined, and hopefully more pragmatic
academic.oup.com/jcem/advance...
Reposted by Adina Turcu
a5-adrenal.bsky.social
A5 meeting under way in San Francisco, led by our executive chair Dr Habra.
#adrenal
Reposted by Adina Turcu
garydouglashammer.bsky.social
@lmfendo.bsky.social at @endocrinesociety.bsky.social #ENDO2025 presents new data on modifier genes in paraganglioma-pheochromocytoma from GWAS studies with close to 2000 tumor samples from @a5-adrenal.bsky.social teams around the globe. New targets, new biology. Hope for new therapies!
Reposted by Adina Turcu
endocrinesociety.bsky.social
Editor-in-Chief @zane-andrews.bsky.social will be chairing our #Endocrinology Journal Symposium at 8:00 AM in Room 308 to examine GLP-1-based therapies and the emergence of GLP-1-based multi-agonists combining with other hormones: bit.ly/4lMdrku #ENDO2025
@endosocjournals.bsky.social
ENDO25
bit.ly
Reposted by Adina Turcu
endocrinesociety.bsky.social
Get ready for the third day of ENDO | It was great seeing everyone yesterday for a day full of science! We cannot wait to host you tomorrow. Join us for a wide range of networking events. View our program planner and mark your schedule: bit.ly/4nJotbW
Reposted by Adina Turcu
hswapnil.medsky.social
A medical adrenalectomy?

ASIs advance - Baxdrostat in primary aldosteronism now www.nejm.org/doi/full/10.... n = 15 single arm trial from @adinaturcu.bsky.social and @astra-zeneca.bsky.social in @nejm.org

~ 25/10 mm Hg BP lowering and impressive aldosterone level drop

#Hypertension #EndoSky
Efficacy and Side-Effect Profile of Baxdrostat in Patients with Primary Aldosteronism.
Reposted by Adina Turcu
anastasiasmihaili.bsky.social
Congratulations @adinaturcu.bsky.social & co-authors 👏👏

Exciting time for 🔦 on the equally important second “A” in #RAAS 😁
hswapnil.medsky.social
A medical adrenalectomy?

ASIs advance - Baxdrostat in primary aldosteronism now www.nejm.org/doi/full/10.... n = 15 single arm trial from @adinaturcu.bsky.social and @astra-zeneca.bsky.social in @nejm.org

~ 25/10 mm Hg BP lowering and impressive aldosterone level drop

#Hypertension #EndoSky
Efficacy and Side-Effect Profile of Baxdrostat in Patients with Primary Aldosteronism.
Reposted by Adina Turcu
garydouglashammer.bsky.social
Outstanding talk here at @endocrineoncology.bsky.social #ENDO2025 on adrenal Cushing genomics by University of Michigan adrenal team member Juilee Rege here at #ENDO2025. Go Juilee, Go Blue, Go @A5-Alliance
Reposted by Adina Turcu
nejm.org
NEJM.org @nejm.org · Jul 13
In 15 patients with primary aldosteronism, baxdrostat (a second-generation, nonimidazole aldosterone synthase inhibitor) resolved or reduced the severity of hypertension, excessive aldosterone production, and hypokalemia. Full SPARK study results: nej.md/40Js1kz

#ENDO2025
A figure showing the changes from baseline in systolic blood pressure (SBP), plasma aldosterone–renin ratio (ARR), and serum potassium level for each patient.
Reposted by Adina Turcu
esendocrinology.bsky.social
Join us! ESE Talks...Rare Diseases - CAH; diagnostic and therapeutic challenges across the entire lifespan - A joint webinar with ESE, Endo-ERN and ESPE.

📅 2 September, 17:00-18:30 CEST

Register for free 👉 ow.ly/I29350W2XNp
#RareDiseases #CAH #Endocrinology
Reposted by Adina Turcu
nadfadrenal.bsky.social
Accurate steroid replacement is essential for children with adrenal insufficiency, but giving medication to kids can be a game of cat and mouse. Hydrocortisone granules are a game changer. Read more: NADF.us/children-with-adrenal-insufficiency

#AADAM2025 #AdrenalDiseaseAwareness #AdrenalDisease
Hexagonal photo of small child running away. Text reads, "Tricky customer? Try hydrocortisone granules! Accurate steroid replacement dosing is imperative to health in children and infants with adrenal insufficiency. ALKINDI SPRINKLE is a granular version of hydrocortisone developed and approved for the treatment of adrenal insufficiency in newborns and children: small enough to sprinkle onto soft food, like yogurt or applesauce, or directly into your child’s mouth. Read more on treating adrenal insufficiency in children: NADF.us/children-with-adrenal-insufficiency. #AADAM2025 April is Adrenal Disease Awareness Month. NADF.us/april-calendar."
Reposted by Adina Turcu
nadfadrenal.bsky.social
Register today for the Adrenal Disease Awareness Month Webinar with #AAES and #NADFAdrenal. We are excited to bring you this annual event as part of #AADAM2025.

April 10, 2025 - 8pm EST / 5pm PST
Visit bit.ly/AAES-NADF to register
Coming soon! Adrenal Disease Awareness Month Webinar. Thursday, April 10, 2025. 8:00PM EST (5:00PM EST). Register today: bit.ly/AAES-NADF #AADAM2025 April Is Adrenal Disease Awareness month. NADF.us/april-calendar. Headshots of Dr. Paul Graham, Dr. Amir Hamrahian, Dr. Philip Smith, and Dr. Carmen Solórzano, and moderators Dr. Lilah Morris-Wiseman and Dr. Susana Vargas Pinto.
Reposted by Adina Turcu
jci.org
Thanks to @UshmaNeill for running the Conversation of Giants in Medicine series for over a decade. Since its inception in 2012, this series has spanned 74 interviews with 80 pioneer scientists: jci.org/videos/cgms

Last but not least episode:
Video: buff.ly/LF6DMYz
Article: jci.org/articles/vie...
JCI’s Conversations with Giants in Medicine: Ending one conversation
Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.
buff.ly
Reposted by Adina Turcu
fbeuschlein.bsky.social
Interesting news recycling. Looking forward to this year’s presentation from Ashley Grossman www.ese-hormones.org/what-we-do/a...